Lobbying Activity Report

2606-8309

Organization: sanofi-aventis Canada Inc.
Associated registration: 7146-2606-14
Lobbying Activity date: 2021-03-30
Arranged a meeting: No
Posted date: 2021-04-15

In-house lobbyists who participated in the lobbying activity: Daniel Kennedy
Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, Assistant Deputy Minister
PBLSD, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Negotiate funding parameters for Admelog - a biosimilar insulin
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
Participate in the MS Class Review project undertaken by the Pharmaceutical Services Division of the Ministry of Health
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
Negotiate the listing of Dupixent on the BC PharmaCare formulary Footnote1
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health Footnote1
 
Senior officer who filed this Lobbying Activity Report: Marissa Poole
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: